The evolving story of incretins (GIP and GLP‐1) in metabolic and cardiovascular disease: a pathophysiological update
MA Nauck, DR Quast, J Wefers… - Diabetes, Obesity and …, 2021 - Wiley Online Library
The incretin hormones glucose‐dependent insulinotropic polypeptide (GIP) and glucagon‐
like peptide‐1 (GLP‐1) have their main physiological role in augmenting insulin secretion …
like peptide‐1 (GLP‐1) have their main physiological role in augmenting insulin secretion …
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases
Insulin and glucagon exert opposing effects on glucose metabolism and, consequently,
pancreatic islet β-cells and α-cells are considered functional antagonists. The intra-islet …
pancreatic islet β-cells and α-cells are considered functional antagonists. The intra-islet …
Incretin hormones: Their role in health and disease
MA Nauck, JJ Meier - Diabetes, Obesity and Metabolism, 2018 - Wiley Online Library
Incretin hormones are gut peptides that are secreted after nutrient intake and stimulate
insulin secretion together with hyperglycaemia. GIP (glucose‐dependent insulinotropic …
insulin secretion together with hyperglycaemia. GIP (glucose‐dependent insulinotropic …
The cells of the islets of Langerhans
G Da Silva Xavier - Journal of clinical medicine, 2018 - mdpi.com
Islets of Langerhans are islands of endocrine cells scattered throughout the pancreas. A
number of new studies have pointed to the potential for conversion of non-β islet cells in to …
number of new studies have pointed to the potential for conversion of non-β islet cells in to …
Insulin secretion depends on intra-islet glucagon signaling
B Svendsen, O Larsen, MBN Gabe, CB Christiansen… - Cell reports, 2018 - cell.com
The intra-islet theory states that glucagon secretion is suppressed when insulin secretion is
stimulated, but glucagon's role in intra-islet paracrine regulation is controversial. This study …
stimulated, but glucagon's role in intra-islet paracrine regulation is controversial. This study …
The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
MA Nauck, JJ Meier - The lancet Diabetes & endocrinology, 2016 - thelancet.com
The incretin effect describes the phenomenon whereby oral glucose elicits higher insulin
secretory responses than does intravenous glucose, despite inducing similar levels of …
secretory responses than does intravenous glucose, despite inducing similar levels of …
100 years of glucagon and 100 more
NJ Wewer Albrechtsen, JJ Holst, AD Cherrington… - Diabetologia, 2023 - Springer
The peptide hormone glucagon, discovered in late 1922, is secreted from pancreatic alpha
cells and is an essential regulator of metabolic homeostasis. This review summarises …
cells and is an essential regulator of metabolic homeostasis. This review summarises …
Microvesicles and exosomes: new players in metabolic and cardiovascular disease
C Lawson, JM Vicencio, DM Yellon… - Journal of …, 2016 - joe.bioscientifica.com
The past decade has witnessed an exponential increase in the number of publications
referring to extracellular vesicles (EVs). For many years considered to be extracellular …
referring to extracellular vesicles (EVs). For many years considered to be extracellular …
Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy
RA Rizza - Diabetes, 2010 - Am Diabetes Assoc
The objective of this research is to gain a greater understanding of the cause of fasting and
postprandial hyperglycemia in people with type 2 diabetes. Endogenous glucose production …
postprandial hyperglycemia in people with type 2 diabetes. Endogenous glucose production …
Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies
Aims/hypothesis We carried out a systematic review of clinical studies investigating
glucagon-like peptide-1 (GLP-1) secretion in patients with type 2 diabetes and non-diabetic …
glucagon-like peptide-1 (GLP-1) secretion in patients with type 2 diabetes and non-diabetic …